Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study.
Tsai HJ, Shan YS, Yang CY, Hsiao CF, Tsai CH, Wang CC, Lin MT, Ting CF, Chan DC, Chen TH, Yen CC, Chen YY, Lin HY, Yeh TS, Ho CL, Shieh TY, Bai LY, Hsu JT, Chen IS, Chen LT, Yeh CN; Taiwan Cooperative Oncology Group (TCOG) GIST Study Group. Tsai HJ, et al. Among authors: bai ly. BMC Cancer. 2024 Jul 11;24(1):828. doi: 10.1186/s12885-024-12567-1. BMC Cancer. 2024. PMID: 38992597 Free PMC article.
Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL study.
Kuo CY, Wang PN, Hwang WL, Tzeng CH, Bai LY, Tang JL, Chang MC, Lin SF, Chen TY, Chen YC, Tan TD, Hsieh CY, Lin C, Lai C, Miljkovic D, Chang CS. Kuo CY, et al. Among authors: bai ly. Ther Adv Hematol. 2018 Mar;9(3):65-78. doi: 10.1177/2040620718756603. Epub 2018 Mar 4. Ther Adv Hematol. 2018. PMID: 29531660 Free PMC article.
All-trans retinoic acid-mediated ADAR1 degradation synergizes with PD-1 blockade to suppress pancreatic cancer.
Li CF, Bai LY, Wei Y, Lee HH, Yang R, Yao J, Wang H, Wang YN, Chang WC, Shen YC, Wang SC, Chou CW, Fu J, Ling J, Chu YY, Chiu CF, Wang M, Yu D, Chiao PJ, Liang H, Maitra A, Ying H, Hung MC. Li CF, et al. Among authors: bai ly. bioRxiv [Preprint]. 2024 Oct 23:2024.10.20.619300. doi: 10.1101/2024.10.20.619300. bioRxiv. 2024. PMID: 39484589 Free PMC article. Preprint.
Two new abietane diterpenoids from Caryopteris trichosphaera.
Lu QY, Wang ZJ, Bai LY, Zu WB, Zhou ZS, Zhu YY, He XC, Zhao YL, Luo XD. Lu QY, et al. Among authors: bai ly. Fitoterapia. 2024 Dec;179:106269. doi: 10.1016/j.fitote.2024.106269. Epub 2024 Oct 23. Fitoterapia. 2024. PMID: 39454891
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer.
Pavlakis N, Shitara K, Sjoquist K, Martin A, Jaworski A, Tebbutt N, Bang YJ, Alcindor T, O'Callaghan C, Strickland A, Rha SY, Lee KW, Kim JS, Bai LY, Hara H, Oh DY, Yip S, Zalcberg J, Price T, Simes J, Goldstein D. Pavlakis N, et al. Among authors: bai ly. J Clin Oncol. 2024 Oct 4:JCO2400055. doi: 10.1200/JCO.24.00055. Online ahead of print. J Clin Oncol. 2024. PMID: 39365958
Phase I-II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors.
Tsimberidou AM, Grothey A, Sigal D, Lenz HJ, Hochster HS, Chao Y, Bai LY, Yen CL, Xu D, Saville MW. Tsimberidou AM, et al. Among authors: bai ly. Cancer Chemother Pharmacol. 2024 Dec;94(6):787-798. doi: 10.1007/s00280-024-04714-z. Epub 2024 Sep 23. Cancer Chemother Pharmacol. 2024. PMID: 39311947 Free PMC article. Clinical Trial.
213 results